North Korea reports 40,060 more people with fever symptoms amid COVID-19 outbreak—KCNA | Inquirer News

North Korea reports 40,060 more people with fever symptoms amid COVID-19 outbreak—KCNA

/ 10:47 AM June 12, 2022

North Korea reports 40,060 more people with fever symptoms amid COVID-19 outbreak—KCNA

Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea’s Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo

SEOUL — North Korea on Sunday reported 40,060 new people showing fever symptoms and one death amid the isolated nation’s first confirmed COVID-19 outbreak, state media KCNA said.

RELATED STORIES

Article continues after this advertisement

North Korea reports 54,610 more people with fever symptoms—KCNA

FEATURED STORIES

North Korea’s COVID-19 narratives as told through Rodong Sinmun

North Korea reports 21 new deaths as it battles COVID outbreak

Article continues after this advertisement

North Korea hails ‘good results’ on COVID as fever cases pass 2 million

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health, North Korea

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.